Qiagen NV | QIA - Ebit

Aktienkurs
29.47
Täglich Wechseln
0.87 3.02%
Monatlich
-15.69%
Jährlich
-22.74%
Q2 Prognose
27.85




Ebit Veränderung Datum
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
argenx SE USD 394M 22.86M 2026-03
Avita Medical AUD -10.39M 1.72M 2025-12
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Ionis Pharmaceuticals USD -118M 97M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
Moderna USD -1.39B 531M 2026-03
Organon & Co USD -27M 415M 2025-12
Qiagen NV USD 121.88M 19.18M 2025-12
Revvity USD 82.77M 63.06M 2026-03
Tectonic Therapeutic USD -21.52M 374K 2025-12
Viatris USD -20.2M 137.3M 2026-03
Xeris Pharmaceuticals USD 16.77M 8.88M 2025-12